CARIS LIFE SCIENCES, INC. for CARIS LIFE SCIENCES, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Insurance INS
Patient Protection and Affordable Care Act (PPACA) implementation issues; Coverage and pricing policies for molecular diagnostic cancer tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | Asst. to the Speaker of the House for Policy |
Health Issues HCR
Patient Protection and Affordable Care Act (PPACA) implementation issues; Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule; President Obama's FY2015 Medicare funding proposals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | Asst. to the Speaker of the House for Policy |
Medicare/Medicaid MMM
Sustainable Growth Rate reform; Clinical lab and physician fee schedule reforms and beneficiary cost sharing proposals; President Obama's FY2015 Medicare funding proposals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | Asst. to the Speaker of the House for Policy |
Medical/Disease Research/Clinical Labs MED
Patient Protection and Affordable Care Act (PPACA) implementation issues; Budget Control Act of 2011; Sustainable Growth Rate reform; Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule; President Obama's FY2015 Medicare funding proposals; advanced molecular diagnostic policy; lab and pathology coverage and payment issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | Asst. to Speaker of the House for Policy |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.